000 01436 a2200373 4500
005 20250515161828.0
264 0 _c20090819
008 200908s 0 0 eng d
022 _a1531-8257
024 7 _a10.1002/mds.22450
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDevos, David
245 0 0 _aPatient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
_h[electronic resource]
260 _bMovement disorders : official journal of the Movement Disorder Society
_cMay 2009
300 _a993-1000 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Multicenter Study
650 0 4 _aAged
650 0 4 _aAntiparkinson Agents
_xadverse effects
650 0 4 _aDementia
_xdrug therapy
650 0 4 _aDuodenum
_xphysiology
650 0 4 _aFemale
650 0 4 _aGait Disorders, Neurologic
_xdrug therapy
650 0 4 _aHallucinations
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLevodopa
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aParkinson Disease
_xcomplications
650 0 4 _aPersonal Autonomy
650 0 4 _aQuality of Life
_xpsychology
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
773 0 _tMovement disorders : official journal of the Movement Disorder Society
_gvol. 24
_gno. 7
_gp. 993-1000
856 4 0 _uhttps://doi.org/10.1002/mds.22450
_zAvailable from publisher's website
999 _c18694523
_d18694523